FGFR2 and neoplasm: Foundation One Liquid CDx test results were as follows: microsatellite instability-high, not detected; tumor mutational burden, intermediate (7.59 Muts/Mb); FGFR2 missense variant, c.1144T>C; PTEN missense variant, c.335T>C; and TP53 missense variant, c.722C>T.